ATC Group: H03A Thyroid preparations

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of H03A in the ATC hierarchy

Level Code Title
1 H Systemic hormonal preparations, excl. Sex hormones and insulins
2 H03 Thyroid therapy
3 H03A Thyroid preparations

Group H03A contents

Code Title
H03AA Thyroid hormones

Active ingredients in H03A

Active Ingredient Description
Levothyroxine

Levothyroxine sodium is used for the treatment of hypothyroidism. The chief action of levothyroxine is to increase the rate of cell metabolism.

Liothyronine

Liothyronine sodium is a naturally occurring thyroid hormone. The biological action of liothyronine sodium is quantitatively similar to that of levothyroxine sodium.

Tiratricol

Related product monographs

Title Information Source Document Type  
CYTOMEL Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
ELTROXIN Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EUTHYROX Tablet Marketing Authorisation Holder MPI, EU: SmPC
LEVOXYL Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
OROXINE Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
SYNTHROID Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
TIROSINT Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR